Midkine (MK), a retinoic acid (RA)-inducible gene product, produced in E. Coli acts on neuronal and HL60 leukemia cells

H. Maruta, P. F. Bartlett, V. Nurcombe, M. S.A. Nur-e-Kamal, C. Chomienne, T. Muramatsu, H. Muramatsu, L. Fabri, E. Nice, A. W. Burgess

Research output: Contribution to journalArticleResearchpeer-review

34 Citations (Scopus)


We have shown previously that (i) retinoic acid (RA), an anti-neoplastic agent, activates the midkine (MK) gene in mammalian embryonic carcinoma cells, and that (ii) the MK of 118 amino acids, purified from L cells, induces neurite outgrowth of mammalian embryonic brain cells. In this paper, we describe an unconventional strategy for the purification of a fully active MK from E. coli with a high yield. The MK was overproduced in E. coli as a glutathione S-transferase (GST) fusion protein. The MK fusion protein extracted from the bacterial inclusion bodies with guanidine-HCl was renatured, refolded slowly and cleaved by thrombin at the site where the GST links to the MK. The purified free MK, like RA, induced neurite outgrowth from central neurons of the mouse spinal cord, and suppressed the growth of human HL60 leukemia cells in vitro. Unlike RA, however, the MK did not induce granulocytic differentiation of HL60 cells. Furthermore, the MK supported the survival of an NGF-insensitive sensory neuron subpopulation(s) from chicken embryo dorsal root ganglion. Thus, the actions of the MK and leukemia inhibitory factor (LIF) are surprisingly similar. There is no sequence similarity between MK and LIF, however, and unlike MK, LIF production does not appear to be RA-inducible.

Original languageEnglish
Pages (from-to)119-134
Number of pages16
JournalGrowth Factors
Issue number2
Publication statusPublished - 1 Jan 1993
Externally publishedYes


  • HL60 cells
  • Leukemia inhibitory factor (LIF)
  • MK
  • Neuronal differentiation
  • PTN
  • Retinoic acid

Cite this